biote Revenue

In the year 2023, biote had annual revenue of $185.36M with 12.37% growth. Revenue in the quarter ending December 31, 2023 was $45.70M with 2.74% year-over-year growth.

Revenue (ttm)

$185.36M

Revenue Growth

+12.37%

P/S Ratio

2.32

Revenue / Employee

$955,464

Employees

194

Market Cap

430.79M USD

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	185.36M	20.40M	12.37%
Dec 31, 2022	164.96M	25.56M	18.34%
Dec 31, 2021	139.40M	22.83M	19.58%
Dec 31, 2020	116.57M	6.59M	5.99%
Dec 31, 2019	109.98M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Aveanna Healthcare Holdings	1.90B
MultiPlan	961.52M
ZimVie	457.43M
Adaptive Biotechnologies	170.28M
C4 Therapeutics	20.76M
Lexicon Pharmaceuticals	2.31M

Revenue Rankings

BTMD News

3 days ago - Biote Announces Definitive Settlement with Founder - Business Wire
9 days ago - Biote Schedules First Quarter 2024 Financial Results Release and Conference Call - Business Wire
6 weeks ago - This overlooked corner of women's health could be a $350 billion market opportunity - CNBC
7 weeks ago - Biote Reports Fourth Quarter and Full Year 2023 Financial Results - Business Wire
2 months ago - Biote Schedules Fourth Quarter and Full Year 2023 Financial Results Release and Conference Call - Business Wire
2 months ago - Biote Announces Agreement to Resolve Litigation and Repurchase All of Founder's Shares - Business Wire
3 months ago - Biote Announces $20 Million Share Repurchase Authorization - Business Wire
3 months ago - Biote to Purchase Asteria Health - Business Wire

More News